# OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.

> **NCT00681850** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 4027 (actual)

## Conditions studied

- Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00681850
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 4027 (ACTUAL)
- **Last updated:** 2020-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00681850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00681850, "OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00681850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*